{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,27]],"date-time":"2025-11-27T20:59:44Z","timestamp":1764277184630,"version":"3.44.0"},"reference-count":24,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2023,5,1]],"date-time":"2023-05-01T00:00:00Z","timestamp":1682899200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,5,1]],"date-time":"2023-05-01T00:00:00Z","timestamp":1682899200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Current Problems in Cardiology"],"published-print":{"date-parts":[[2023,5]]},"DOI":"10.1016\/j.cpcardiol.2023.101609","type":"journal-article","created":{"date-parts":[[2023,1,21]],"date-time":"2023-01-21T02:08:13Z","timestamp":1674266893000},"page":"101609","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"title":["Differences in the Clinical Outcome of Ischemic and Nonischemic Cardiomyopathy in Heart Failure With Concomitant Opioid Use Disorder"],"prefix":"10.1016","volume":"48","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0936-5009","authenticated-orcid":false,"given":"John","family":"Gharbin","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Adwoa","family":"Winful","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mubariz Ahmed","family":"Hassan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Siddharth","family":"Bajaj","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yashvardhan","family":"Batta","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pamela","family":"Alebna","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Suchellis","family":"Rhodd","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mohammed","family":"Taha","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Urooj","family":"Fatima","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Prafulla","family":"Mehrotra","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.cpcardiol.2023.101609_bib0001","doi-asserted-by":"crossref","first-page":"e56","DOI":"10.1161\/CIR.0000000000000659","article-title":"Heart disease and stroke statistics-2019 update: a report from the American Heart Association","volume":"139","author":"Benjamin","year":"2019","journal-title":"Circulation"},{"key":"10.1016\/j.cpcardiol.2023.101609_bib0002","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1186\/s12916-018-1058-y","article-title":"Healthcare costs and utilization associated with high-risk prescription opioid use: a retrospective cohort study","volume":"16","author":"Chang","year":"2018","journal-title":"BMC Med"},{"key":"10.1016\/j.cpcardiol.2023.101609_bib0003","series-title":"Drug overdose deaths in the United States, 1999\u20132018","first-page":"356","author":"Hedegaard","year":"2020"},{"key":"10.1016\/j.cpcardiol.2023.101609_bib0004","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1001\/jamacardio.2018.4729","article-title":"Analysis of outcomes in ischemic vs nonischemic cardiomyopathy in patients with atrial fibrillation: a report from the GARFIELD-AF registry","volume":"4","author":"Corbalan","year":"2019","journal-title":"JAMA Cardiology"},{"key":"10.1016\/j.cpcardiol.2023.101609_bib0005","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1016\/j.ijcard.2007.07.014","article-title":"Differences in management and outcome of ischemic and non-ischemic cardiomyopathy","volume":"129","author":"Ng","year":"2008","journal-title":"Int J Cardiol"},{"volume":"2022","year":"2022","key":"10.1016\/j.cpcardiol.2023.101609_bib0006"},{"key":"10.1016\/j.cpcardiol.2023.101609_bib0007","doi-asserted-by":"crossref","first-page":"1002","DOI":"10.1016\/S0735-1097(97)00235-0","article-title":"Clinical determinants of mortality in patients with angiographically diagnosed ischemic or nonischemic cardiomyopathy","volume":"30","author":"Bart","year":"1997","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.cpcardiol.2023.101609_bib0008","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.ijcard.2016.08.316","article-title":"Mortality in systolic heart failure revisited: Ischemic versus non-ischemic cardiomyopathy","volume":"224","author":"Gajanana","year":"2016","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.cpcardiol.2023.101609_bib0009","first-page":"34","article-title":"Extent of left ventricular scar predicts outcomes in ischemic cardiomyopathy patients with significantly reduced systolic function: a delayed hyperenhancement cardiac magnetic resonance study","volume":"2","author":"Kwon","year":"2009","journal-title":"Cardiovasc Imaging"},{"key":"10.1016\/j.cpcardiol.2023.101609_bib0010","doi-asserted-by":"crossref","first-page":"3411","DOI":"10.1161\/CIRCULATIONAHA.104.508093","article-title":"Changes in ventricular size and function in patients treated with valsartan, captopril, or both after myocardial infarction","volume":"111","author":"Solomon","year":"2005","journal-title":"Circulation"},{"key":"10.1016\/j.cpcardiol.2023.101609_bib0011","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1161\/01.CIR.76.1.44","article-title":"Left ventricular end-systolic volume as the major determinant of survival after recovery from myocardial infarction","volume":"76","author":"White","year":"1987","journal-title":"Circulation"},{"key":"10.1016\/j.cpcardiol.2023.101609_bib0012","doi-asserted-by":"crossref","first-page":"931","DOI":"10.3390\/jcm9040931","article-title":"Patient characteristics, treatment and outcome in non-ischemic vs. ischemic cardiogenic shock","volume":"9","author":"Schrage","year":"2020","journal-title":"J Clin Med"},{"key":"10.1016\/j.cpcardiol.2023.101609_bib0013","doi-asserted-by":"crossref","first-page":"1295","DOI":"10.1016\/j.amjcard.2004.01.072","article-title":"Coronary artery disease and opioid use","volume":"93","author":"Marmor","year":"2004","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.cpcardiol.2023.101609_bib0014","doi-asserted-by":"crossref","first-page":"1528","DOI":"10.1016\/j.amjcard.2019.07.068","article-title":"Frequency of Cardiovascular Events and In-hospital Mortality With Opioid Overdose Hospitalizations","volume":"124","author":"Doshi","year":"2019","journal-title":"The American Journal of Cardiology"},{"key":"10.1016\/j.cpcardiol.2023.101609_bib0015","doi-asserted-by":"crossref","first-page":"1043","DOI":"10.1016\/j.ahj.2005.02.010","article-title":"Association of intravenous morphine use and outcomes in acute coronary syndromes: results from the CRUSADE Quality Improvement Initiative","volume":"149","author":"Meine","year":"2005","journal-title":"Am Heart J"},{"key":"10.1016\/j.cpcardiol.2023.101609_bib0016","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/j.jacc.2020.11.002","article-title":"Cardiovascular complications of opioid use","volume":"77","author":"Krantz","year":"2021","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.cpcardiol.2023.101609_bib0017","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1093\/cid\/ciab098","article-title":"Characteristics and outcome of acute heart failure in infective endocarditis: focus on cardiogenic shock","volume":"73","author":"Peric\u00e0s","year":"2021","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.cpcardiol.2023.101609_bib0018","doi-asserted-by":"crossref","first-page":"1253","DOI":"10.1002\/ejhf.2525","article-title":"Characteristics, management, and outcomes of patients with left-sided infective endocarditis complicated by heart failure: a substudy of the ESC-EORP EURO-ENDO (European infective endocarditis) registry","volume":"24","author":"Bohbot","year":"2022","journal-title":"Eur J Heart Fail"},{"key":"10.1016\/j.cpcardiol.2023.101609_bib0019","doi-asserted-by":"crossref","first-page":"2129","DOI":"10.1093\/eurheartj\/ehw128","volume":"37","author":"Ponikowski","year":"2016","journal-title":"Eur Heart J"},{"key":"10.1016\/j.cpcardiol.2023.101609_bib0020","doi-asserted-by":"crossref","first-page":"2866","DOI":"10.1093\/eurheartj\/ehl359","article-title":"Atrial fibrillation, ischaemic heart disease, and the risk of death in patients with heart failure","volume":"27","author":"Pedersen","year":"2006","journal-title":"Eur Heart J"},{"key":"10.1016\/j.cpcardiol.2023.101609_bib0021","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1093\/eurjhf\/hfq052","article-title":"Atrial fibrillation in heart failure is associated with an increased risk of death only in patients with ischaemic heart disease","volume":"12","author":"Rauns\u00f8","year":"2010","journal-title":"Eur J Heart Failure"},{"key":"10.1016\/j.cpcardiol.2023.101609_bib0022","doi-asserted-by":"crossref","first-page":"22","DOI":"10.14797\/mdcj-16-1-22","article-title":"Cardiogenic shock in patients with advanced chronic heart failure","volume":"16","author":"Guerrero-Miranda","year":"2020","journal-title":"Methodist Debakey Cardiovasc J"},{"key":"10.1016\/j.cpcardiol.2023.101609_bib0023","doi-asserted-by":"crossref","first-page":"1126","DOI":"10.1016\/j.cardfail.2021.08.010","article-title":"Heart Failure-Related Cardiogenic Shock: Pathophysiology, Evaluation and Management Considerations: Review of Heart Failure-Related Cardiogenic Shock","volume":"27","author":"Abraham","year":"2021","journal-title":"J Card Fail"},{"key":"10.1016\/j.cpcardiol.2023.101609_bib0024","doi-asserted-by":"crossref","first-page":"3594","DOI":"10.1002\/ehf2.13546","article-title":"Outcome of patients with non-ischaemic cardiogenic shock supported by percutaneous left ventricular assist device","volume":"8","author":"Haurand","year":"2021","journal-title":"ESC Heart Failure"}],"container-title":["Current Problems in Cardiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0146280623000269?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0146280623000269?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,27]],"date-time":"2025-09-27T02:05:10Z","timestamp":1758938710000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0146280623000269"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,5]]},"references-count":24,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2023,5]]}},"alternative-id":["S0146280623000269"],"URL":"https:\/\/doi.org\/10.1016\/j.cpcardiol.2023.101609","relation":{},"ISSN":["0146-2806"],"issn-type":[{"type":"print","value":"0146-2806"}],"subject":[],"published":{"date-parts":[[2023,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Differences in the Clinical Outcome of Ischemic and Nonischemic Cardiomyopathy in Heart Failure With Concomitant Opioid Use Disorder","name":"articletitle","label":"Article Title"},{"value":"Current Problems in Cardiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cpcardiol.2023.101609","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"name":"copyright","label":"Copyright"}],"article-number":"101609"}}